Evaluation of the Quality of Life in Patients Referred for Transjugular Intrahepatic Portosystemic Shunt

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-11

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patient with Advanced Chronic Liver Disease often present portal hypertension which may lead to bleading or ascites.

One of the treatment of portal hypertension in these patients is the placement of a Transjugular Intrahepatic Portosystemic Shunt (TIPS).

The indications for placing TIPS take on various clinical presentations, the most classic being digestive haemorrhage by rupture of oesophageal and/or gastric varices and refractory ascites.

TIPS placement involves changes in haemodynamics and liver function that may alter the patients' condition and quality of life.

Very few articles have evaluated the quality of life of these patients and when quality of life is evaluated it is mostly with not adapted or not validated scales.

The main objective of this study is to evaluate the quality of life of patients who have undergone TIPS using a validated and standardised quality of life questionnaire (the SF-36 questionnaire).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

NCT04640116

Liver Diseases Portal Hypertension Cirrhosis, Liver +2 more

UNKNOWN NA

Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness

NCT03352882

Portal Hypertension Liver Fibroses

TERMINATED NA

Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS

NCT03072615

Portal Hypertension Liver Cirrhoses

COMPLETED

Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension

NCT06245798

Hepatic Carcinoma

COMPLETED

Study of Hemodynamic Conditions Measured During Hepatectomy

NCT03371537

Liver Dysfunction Circulatory; Change

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Liver Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Quality of Life assessed with the SF-36 questionnaire

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Patients referred to the TIPS service between January 2012 and October 2020 at the University Hospitals of Strasbourg, with a follow-up period of at least 1 month
* Subjects who have not expressed any opposition to the use of their medical data for research purposes
* For subjects invited to fill in the questionnaires: subject having expressed his/her agreement with the use of his/her medical data in the framework of the current study

Exclusion Criteria

* Diseased patient
* Liver transplant patient following TIPS
* Pregnancy
* Patient in a vulnerable situation
* Patient under court protection, guardianship or trusteeship
* Difficulties in understanding the questionnaire
* Impossible to give the subject informed information (subject in an emergency situation, difficulties in understanding the subject, etc.)
* Subject under legal protection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No